Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
Cancer Medicine|September 21, 2022
The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro-metastasesGilles Houvenaeghel, Alexandre de Nonneville, Nicolas Chopin, et al.
Breast Cancer Research and Treatment|September 22, 2018
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impactGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
Cancers|March 10, 2022
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant ChemotherapySylvie Giacchetti, Lilith Faucheux, Charlotte Gardair, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2013
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasisChristophe J Desmet, Tristan Gallenne, Alexandre Prieur, et al.
Genes & Development|December 6, 2015
Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesisMichel Wassef, Veronica Rodilla, Aurélie Teissandier, et al.
Nature Genetics|November 14, 2006
Regional copy number-independent deregulation of transcription in cancerNicolas Stransky, Céline Vallot, Fabien Reyal, et al.
Breast Cancer Research and Treatment|February 4, 2017
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional studyAlexandre de Nonneville, Anthony Gonçalves, Christophe Zemmour, et al.
Cancer Research|March 1, 2005
Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes--a study of 130 invasive ductal breast carcinomasFabien Reyal, Nicolas Stransky, Isabelle Bernard-Pierrot, et al.
Ebiomedicine|May 8, 2024
Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trialSylvie Giacchetti, Enora Laas, Thomas Bachelot, et al.
Frontiers in Oncology|October 15, 2021
Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving ChemotherapyAlice Hours, Aullene Toussaint, Victoire De Castelbajac, et al.
Pageof 20